Tucatinib acts as an HER2 inhibitor, and in BT474 breast carcinoma cells, it effectively suppresses HER2 phosphorylation. Tucatinib inhibits AKT phosphorylation and induces apoptosis in BT474 cells, rendering it a viable cytotoxic agent for formulating antibody-drug conjugates (ADCs).
Products > ADC Linker, ADC Payload > ADC Payload | Products > ADC Linker, ADC Payload > ADC Payload > Tucatinib
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。